Antileukemic activity of rapamycin in acute myeloid leukemia. 2005

Christian Récher, and Odile Beyne-Rauzy, and Cécile Demur, and Gaëtan Chicanne, and Cédric Dos Santos, and Véronique Mansat-De Mas, and David Benzaquen, and Guy Laurent, and Françoise Huguet, and Bernard Payrastre
Institut National de la Santé et de la Recherche Médicale (Inserm) U563, CPTP, Département d'Oncogenèse et signalisation dans les cellules hématopoïétiques, IFR30, Toulouse, France. recher.c@chu-toulouse.fr

The mammalian target of rapamycin (mTOR) is a key regulator of growth and survival in many cell types. Its constitutive activation has been involved in the pathogenesis of various cancers. In this study, we show that mTOR inhibition by rapamycin strongly inhibits the growth of the most immature acute myeloid leukemia (AML) cell lines through blockade in G0/G1 phase of the cell cycle. Accordingly, 2 downstream effectors of mTOR, 4E-BP1 and p70S6K, are phosphorylated in a rapamycin-sensitive manner in a series of 23 AML cases. Interestingly, the mTOR inhibitor markedly impairs the clonogenic properties of fresh AML cells while sparing normal hematopoietic progenitors. Moreover, rapamycin induces significant clinical responses in 4 of 9 patients with either refractory/relapsed de novo AML or secondary AML. Overall, our data strongly suggest that mTOR is aberrantly regulated in most AML cells and that rapamycin and analogs, by targeting the clonogenic compartment of the leukemic clone, may be used as new compounds in AML therapy.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010750 Phosphoproteins Phosphoprotein
D010766 Phosphorylation The introduction of a phosphoryl group into a compound through the formation of an ester bond between the compound and a phosphorus moiety. Phosphorylations
D011494 Protein Kinases A family of enzymes that catalyze the conversion of ATP and a protein to ADP and a phosphoprotein. Protein Kinase,Kinase, Protein,Kinases, Protein
D011499 Protein Processing, Post-Translational Any of various enzymatically catalyzed post-translational modifications of PEPTIDES or PROTEINS in the cell of origin. These modifications include carboxylation; HYDROXYLATION; ACETYLATION; PHOSPHORYLATION; METHYLATION; GLYCOSYLATION; ubiquitination; oxidation; proteolysis; and crosslinking and result in changes in molecular weight and electrophoretic motility. Amino Acid Modification, Post-Translational,Post-Translational Modification,Post-Translational Protein Modification,Posttranslational Modification,Protein Modification, Post-Translational,Amino Acid Modification, Posttranslational,Post-Translational Amino Acid Modification,Post-Translational Modifications,Post-Translational Protein Processing,Posttranslational Amino Acid Modification,Posttranslational Modifications,Posttranslational Protein Processing,Protein Processing, Post Translational,Protein Processing, Posttranslational,Amino Acid Modification, Post Translational,Modification, Post-Translational,Modification, Post-Translational Protein,Modification, Posttranslational,Modifications, Post-Translational,Modifications, Post-Translational Protein,Modifications, Posttranslational,Post Translational Amino Acid Modification,Post Translational Modification,Post Translational Modifications,Post Translational Protein Modification,Post Translational Protein Processing,Post-Translational Protein Modifications,Processing, Post-Translational Protein,Processing, Posttranslational Protein,Protein Modification, Post Translational,Protein Modifications, Post-Translational
D012008 Recurrence The return of a sign, symptom, or disease after a remission. Recrudescence,Relapse,Recrudescences,Recurrences,Relapses
D005260 Female Females
D006412 Hematopoietic Stem Cells Progenitor cells from which all blood cells derived. They are found primarily in the bone marrow and also in small numbers in the peripheral blood. Colony-Forming Units, Hematopoietic,Progenitor Cells, Hematopoietic,Stem Cells, Hematopoietic,Hematopoietic Progenitor Cells,Cell, Hematopoietic Progenitor,Cell, Hematopoietic Stem,Cells, Hematopoietic Progenitor,Cells, Hematopoietic Stem,Colony Forming Units, Hematopoietic,Colony-Forming Unit, Hematopoietic,Hematopoietic Colony-Forming Unit,Hematopoietic Colony-Forming Units,Hematopoietic Progenitor Cell,Hematopoietic Stem Cell,Progenitor Cell, Hematopoietic,Stem Cell, Hematopoietic,Unit, Hematopoietic Colony-Forming,Units, Hematopoietic Colony-Forming
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

Christian Récher, and Odile Beyne-Rauzy, and Cécile Demur, and Gaëtan Chicanne, and Cédric Dos Santos, and Véronique Mansat-De Mas, and David Benzaquen, and Guy Laurent, and Françoise Huguet, and Bernard Payrastre
January 2017, Frontiers in pharmacology,
Christian Récher, and Odile Beyne-Rauzy, and Cécile Demur, and Gaëtan Chicanne, and Cédric Dos Santos, and Véronique Mansat-De Mas, and David Benzaquen, and Guy Laurent, and Françoise Huguet, and Bernard Payrastre
October 2008, Leukemia research,
Christian Récher, and Odile Beyne-Rauzy, and Cécile Demur, and Gaëtan Chicanne, and Cédric Dos Santos, and Véronique Mansat-De Mas, and David Benzaquen, and Guy Laurent, and Françoise Huguet, and Bernard Payrastre
October 2020, Oncogenesis,
Christian Récher, and Odile Beyne-Rauzy, and Cécile Demur, and Gaëtan Chicanne, and Cédric Dos Santos, and Véronique Mansat-De Mas, and David Benzaquen, and Guy Laurent, and Françoise Huguet, and Bernard Payrastre
April 2015, Leukemia,
Christian Récher, and Odile Beyne-Rauzy, and Cécile Demur, and Gaëtan Chicanne, and Cédric Dos Santos, and Véronique Mansat-De Mas, and David Benzaquen, and Guy Laurent, and Françoise Huguet, and Bernard Payrastre
March 2019, Experimental cell research,
Christian Récher, and Odile Beyne-Rauzy, and Cécile Demur, and Gaëtan Chicanne, and Cédric Dos Santos, and Véronique Mansat-De Mas, and David Benzaquen, and Guy Laurent, and Françoise Huguet, and Bernard Payrastre
August 2020, Blood,
Christian Récher, and Odile Beyne-Rauzy, and Cécile Demur, and Gaëtan Chicanne, and Cédric Dos Santos, and Véronique Mansat-De Mas, and David Benzaquen, and Guy Laurent, and Françoise Huguet, and Bernard Payrastre
January 2021, Clinical cancer research : an official journal of the American Association for Cancer Research,
Christian Récher, and Odile Beyne-Rauzy, and Cécile Demur, and Gaëtan Chicanne, and Cédric Dos Santos, and Véronique Mansat-De Mas, and David Benzaquen, and Guy Laurent, and Françoise Huguet, and Bernard Payrastre
August 2017, Leukemia research,
Christian Récher, and Odile Beyne-Rauzy, and Cécile Demur, and Gaëtan Chicanne, and Cédric Dos Santos, and Véronique Mansat-De Mas, and David Benzaquen, and Guy Laurent, and Françoise Huguet, and Bernard Payrastre
June 2020, Cancers,
Christian Récher, and Odile Beyne-Rauzy, and Cécile Demur, and Gaëtan Chicanne, and Cédric Dos Santos, and Véronique Mansat-De Mas, and David Benzaquen, and Guy Laurent, and Françoise Huguet, and Bernard Payrastre
September 2015, Blood,
Copied contents to your clipboard!